| Cover | May 13, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | May 13, 2024 |
| Entity File Number | 001-39202 |
| Entity Registrant Name | ANNOVIS BIO, INC. |
| Entity Central Index Key | 0001477845 |
| Entity Tax Identification Number | 26-2540421 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | 101 Lindenwood Drive |
| Entity Address, Address Line Two | Suite 225 |
| Entity Address, City or Town | Malvern |
| Entity Address, State or Province | PA |
| Entity Address, Postal Zip Code | 19355 |
| City Area Code | 484 |
| Local Phone Number | 875-3192 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | ANVS |
| Security Exchange Name | NYSE |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
